An inflammatory cytokine signature predicts COVID-19 severity and survivalDiane M. Del Valle, Sacha Gnjatic, Seunghee Kim‐Schulze et al.|Nature Medicine|2020Cited by 2.7k
Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes StudyAndrew Schmidt, Deborah B. Doroshow, Ziad Bakouny et al.|Cancer Cell|2020Cited by 72
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I TrialEdwin R. Parra, Cara Haymaker, Sacha Gnjatic et al.|Clinical Cancer Research|2024Cited by 42
Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes studyZiad Bakouny, Deborah B. Doroshow, C. Labaki et al.|Annals of Oncology|2022Cited by 33
Supplementary Table 5 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I TrialEdwin R. Parra, Cara Haymaker, Jiexin Zhang et al.|Unknown|2024Cited by 0